MAP2K7 and head and neck squamous cell carcinoma: Again, a more detailed analysis in appropriate preclinical models is needed to provide the proof of concept that inhibition of the EGFR-MEK pathway has an impact on CNI and resembles an effective treatment for SChigh HNSCC.